Cellsion wins a prize in the Japan Semi-Final
of the JINJI LAKE STARTUP CONTEST 2023

Review Article on Advances in Corneal Regenerative Medicine with iPS Cells Published in Japanese Journal of Ophthalmology

Cellusion received the MEXT Minister’s Award
under the Award for Academic Startups 2023

Cellusion raises 2.83 Billion Yen (21 Million USD) in Series C Round

Announcement on Appointment of Officers

Dr. Jun Shimazaki, Professor Emeritus of Tokyo Dental College, Appointed as Scientific Advisor to Cellusion

Cellusion exhibits at Tokyo’s Pavilion at Japan Innovation Night

Cellusion participating in the 2023 BIO International Convention
CEO Dr. Hatou will present our business progress

Cellusion selected for METI’s “J-Startup” support program

Cellusion Announces First Patient Transplanted iPSC-Derived Corneal Endothelial Cell Substitute (CLS001)